5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F.F. Cardoso
1
,
Shani Paluch-Shimon
2
,
E Senkus
3
,
M Aapro
5
,
Fabrice Andre
6
,
C H Barrios
7
,
Jonas Bergh
8
,
G.S. Bhattacharyya
9
,
Laura Biganzoli
10
,
Frances Boyle
11
,
M Isabel Cardoso
1, 12
,
L. C. CAREY
13
,
J. Cort??s
14, 15
,
N.S El Saghir
16
,
M Elzayat
17
,
Alexandru Eniu
18
,
L Fallowfield
19
,
Paul Francis
20
,
Karen A Gelmon
21
,
Joseph Gligorov
22
,
Renate Haidinger
23
,
Nadia Harbeck
24
,
X. Hu
25
,
B Kaufman
26
,
R. Kaur
27
,
Barry Kiely
28
,
S.-B. Kim
29
,
Nan Lin
30
,
S A Mertz
31
,
Silvia Neciosup
32
,
Birgitte V. Offersen
33
,
S. Ohno
34
,
O. Pagani
35
,
A. Prat
36, 37, 38
,
Frédérique Penault-Llorca
39, 40
,
Hope S. Rugo
41
,
George W. Sledge
42
,
C. Thomssen
43
,
D. A. Vorobiof
44
,
Theresa Wiseman
45
,
B. Xu
46
,
L. NORTON
47
,
A. Costa
48, 49
,
E.P Winer
30
1
Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal
|
4
5
Breast Center, Clinique de Genolier, Genolier, Switzerland
|
7
Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil
|
9
Department of Medical Oncology, Salt Lake City Medical Centre, Kolkata, India
|
10
Department of Medical Oncology, Nuovo Ospedale di Prato – Istituto Toscano Tumori, Prato, Italy
|
12
Nova Medical School, Lisbon, Portugal
|
13
15
IOB Institute of Oncology, Quiron Group, Madrid & Barcelona, Spain
|
17
Europa Donna, The European Breast Cancer Coalition, Milan, Italy
|
18
Interdisciplinary Oncology Service (SIC), Riviera-Chablais Hospital, Rennaz, Switzerland
|
21
Medical Oncology Department, BC Cancer Agency, Vancouver, Canada
|
22
23
Brustkrebs Deutschland e.V., Munich, Germany
|
24
27
Breast Cancer Welfare Association Malaysia, Petaling Jaya, Malaysia
|
28
NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia
|
29
31
Metastatic Breast Cancer Network, Inverness, USA
|
34
Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan
|
39
Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France
|
40
44
Oncology Research Unit, Belong.Life, Tel Aviv, Israel
|
45
Department of Applied Health Research in Cancer Care, The Royal Marsden Hospital NHS Foundation Trust, London, UK
|
46
48
European School of Oncology, Bellinzona, Switzerland
|
49
European School of Oncology, Milan, Italy
|
Publication type: Journal Article
Publication date: 2020-12-01
scimago Q1
wos Q1
SJR: 19.072
CiteScore: 70.4
Impact factor: 65.4
ISSN: 09237534, 15698041
PubMed ID:
32979513
Oncology
Hematology
Abstract
For the purpose of advanced breast cancer (ABC) guidelines, ABC comprises both inoperable locally advanced breast cancer (LABC) and metastatic breast cancer (MBC).1,2 Advanced/metastatic breast cancer remains a virtually incurable disease, with a median overall survival (OS) of about 3 years and a 5-year survival rate of around 25%,3,4 even in countries without major accessibility problems. Survival is strongly related to breast cancer subtype, with the major advances seen in human epidermal growth factor receptor 2 (HER2)-positive ABC.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
80
|
|
|
Cancers
72 publications, 6.96%
|
|
|
Frontiers in Oncology
52 publications, 5.02%
|
|
|
Breast
40 publications, 3.86%
|
|
|
Breast Cancer Research and Treatment
33 publications, 3.19%
|
|
|
ESMO Open
20 publications, 1.93%
|
|
|
Scientific Reports
18 publications, 1.74%
|
|
|
npj Breast Cancer
16 publications, 1.55%
|
|
|
Therapeutic Advances in Medical Oncology
15 publications, 1.45%
|
|
|
European Journal of Cancer
15 publications, 1.45%
|
|
|
Journal of Clinical Oncology
15 publications, 1.45%
|
|
|
International Journal of Molecular Sciences
14 publications, 1.35%
|
|
|
Annals of Oncology
14 publications, 1.35%
|
|
|
BMC Cancer
13 publications, 1.26%
|
|
|
Breast Cancer
13 publications, 1.26%
|
|
|
Breast Cancer Research
11 publications, 1.06%
|
|
|
Cancer Medicine
10 publications, 0.97%
|
|
|
Future Oncology
9 publications, 0.87%
|
|
|
Journal of Clinical Medicine
9 publications, 0.87%
|
|
|
Diagnostics
9 publications, 0.87%
|
|
|
Current Oncology
9 publications, 0.87%
|
|
|
Journal of Modern Oncology
9 publications, 0.87%
|
|
|
Clinical and Translational Oncology
8 publications, 0.77%
|
|
|
Clinical Breast Cancer
8 publications, 0.77%
|
|
|
Translational Breast Cancer Research
8 publications, 0.77%
|
|
|
Cancer Treatment Reviews
7 publications, 0.68%
|
|
|
Critical Reviews in Oncology/Hematology
7 publications, 0.68%
|
|
|
International Journal of Cancer
7 publications, 0.68%
|
|
|
Meditsinskiy sovet = Medical Council
7 publications, 0.68%
|
|
|
Breast Care
6 publications, 0.58%
|
|
|
10
20
30
40
50
60
70
80
|
Publishers
|
50
100
150
200
250
|
|
|
Springer Nature
234 publications, 22.61%
|
|
|
Elsevier
223 publications, 21.55%
|
|
|
MDPI
139 publications, 13.43%
|
|
|
Frontiers Media S.A.
71 publications, 6.86%
|
|
|
Wiley
53 publications, 5.12%
|
|
|
Taylor & Francis
46 publications, 4.44%
|
|
|
SAGE
29 publications, 2.8%
|
|
|
American Society of Clinical Oncology (ASCO)
24 publications, 2.32%
|
|
|
AME Publishing Company
20 publications, 1.93%
|
|
|
Georg Thieme Verlag KG
15 publications, 1.45%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
14 publications, 1.35%
|
|
|
S. Karger AG
11 publications, 1.06%
|
|
|
Consilium Medicum
9 publications, 0.87%
|
|
|
American Association for Cancer Research (AACR)
8 publications, 0.77%
|
|
|
Spandidos Publications
7 publications, 0.68%
|
|
|
Public Library of Science (PLoS)
7 publications, 0.68%
|
|
|
Remedium, Ltd.
7 publications, 0.68%
|
|
|
Massachusetts Medical Society
6 publications, 0.58%
|
|
|
Oxford University Press
6 publications, 0.58%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 0.58%
|
|
|
JMIR Publications
5 publications, 0.48%
|
|
|
Society for Translational Oncology
5 publications, 0.48%
|
|
|
Bentham Science Publishers Ltd.
4 publications, 0.39%
|
|
|
Publishing House ABV Press
4 publications, 0.39%
|
|
|
BMJ
3 publications, 0.29%
|
|
|
Eco-Vector LLC
3 publications, 0.29%
|
|
|
Research Square Platform LLC
3 publications, 0.29%
|
|
|
OAE Publishing Inc.
3 publications, 0.29%
|
|
|
Bioscientifica
2 publications, 0.19%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1k
Total citations:
1036
Citations from 2024:
371
(35.84%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Cardoso F. et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) // Annals of Oncology. 2020. Vol. 31. No. 12. pp. 1623-1649.
GOST all authors (up to 50)
Copy
Cardoso F. et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) // Annals of Oncology. 2020. Vol. 31. No. 12. pp. 1623-1649.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.annonc.2020.09.010
UR - https://doi.org/10.1016/j.annonc.2020.09.010
TI - 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
T2 - Annals of Oncology
AU - Cardoso, F.F.
AU - Paluch-Shimon, Shani
AU - Senkus, E
AU - Curigliano, Giuseppe
AU - Aapro, M
AU - Andre, Fabrice
AU - Barrios, C H
AU - Bergh, Jonas
AU - Bhattacharyya, G.S.
AU - Biganzoli, Laura
AU - Boyle, Frances
AU - Cardoso, M Isabel
AU - CAREY, L. C.
AU - Cort??s, J.
AU - El Saghir, N.S
AU - Elzayat, M
AU - Eniu, Alexandru
AU - Fallowfield, L
AU - Francis, Paul
AU - Gelmon, Karen A
AU - Gligorov, Joseph
AU - Haidinger, Renate
AU - Harbeck, Nadia
AU - Hu, X.
AU - Kaufman, B
AU - Kaur, R.
AU - Kiely, Barry
AU - Kim, S.-B.
AU - Lin, Nan
AU - Mertz, S A
AU - Neciosup, Silvia
AU - Offersen, Birgitte V.
AU - Ohno, S.
AU - Pagani, O.
AU - Prat, A.
AU - Penault-Llorca, Frédérique
AU - Rugo, Hope S.
AU - Sledge, George W.
AU - Thomssen, C.
AU - Vorobiof, D. A.
AU - Wiseman, Theresa
AU - Xu, B.
AU - NORTON, L.
AU - Costa, A.
AU - Winer, E.P
PY - 2020
DA - 2020/12/01
PB - Elsevier
SP - 1623-1649
IS - 12
VL - 31
PMID - 32979513
SN - 0923-7534
SN - 1569-8041
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Cardoso,
author = {F.F. Cardoso and Shani Paluch-Shimon and E Senkus and Giuseppe Curigliano and M Aapro and Fabrice Andre and C H Barrios and Jonas Bergh and G.S. Bhattacharyya and Laura Biganzoli and Frances Boyle and M Isabel Cardoso and L. C. CAREY and J. Cort??s and N.S El Saghir and M Elzayat and Alexandru Eniu and L Fallowfield and Paul Francis and Karen A Gelmon and Joseph Gligorov and Renate Haidinger and Nadia Harbeck and X. Hu and B Kaufman and R. Kaur and Barry Kiely and S.-B. Kim and Nan Lin and S A Mertz and Silvia Neciosup and Birgitte V. Offersen and S. Ohno and O. Pagani and A. Prat and Frédérique Penault-Llorca and Hope S. Rugo and George W. Sledge and C. Thomssen and D. A. Vorobiof and Theresa Wiseman and B. Xu and L. NORTON and A. Costa and E.P Winer and others},
title = {5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)},
journal = {Annals of Oncology},
year = {2020},
volume = {31},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/j.annonc.2020.09.010},
number = {12},
pages = {1623--1649},
doi = {10.1016/j.annonc.2020.09.010}
}
Cite this
MLA
Copy
Cardoso, F., et al. “5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).” Annals of Oncology, vol. 31, no. 12, Dec. 2020, pp. 1623-1649. https://doi.org/10.1016/j.annonc.2020.09.010.